Pharmacoepidemiology Publications

Antihypertensive Deprescribing in Older Adult Veterans at End of Life Admitted to Veteran Affairs Nursing Homes
Michelle Vu, Florentina E Sileanu, Sherrie L Aspinall, Joshua D Niznik, Sydney P Springer, Maria K Mor, Xinhua Zhao, Mary Ersek, Joseph T Hanlon, Walid F Gellad, Loren J Schleiden, Joshua M Thorpe, Carolyn T Thorpe 
Journal of the American Medical Directors Association, July 25, 2020

Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation
Lanting Yang MPH, Maria M. Brooks PhD, Nancy W. Glynn PhD, Yuting Zhang PhD, Samir Saba MD, Inmaculada Hernandez PharmD, PhD
The American Journal of Cardiology, July 1, 2020

Comparison of Oral Anticoagulant Use and Stroke Risk among Older Adults Newly-Diagnosed Atrial Fibrillation Living in Urban-vs-Rural Areas
Jingchuan Guo MD PhD, Meiqi He MS, Jared W Magnani MD, Maria M Brooks PhD, Walid F Gellad MD, Inmaculada Hernandez PharmD PhD
The American Journal of Cardiology, June 17, 2020

A Multifaceted Antimicrobial Stewardship Program for the Treatment of Uncomplicated Cystitis in Nursing Home Residents
David A. Nace, MD, MPH; Joseph T. Hanlon, PharmD, MS; Christopher J. Crnich, MD, PhD; Paul J. Drinka, MD; Steven J. Schweon, RN; Gulsum Anderson, PhD; Subashan Perera, PhD
JAMA Internal Medicine, May 11, 2020

Risk Factors for Cardiovascular Events in Patients on Antidementia Medications
Meiqi He, MS, James M. Stevenson, PharmD, MS, Yuting Zhang, PhD, Inmaculada Hernandez, PharmD, PhD
American Journal of Alzheimer's Disease & Other Dementias, May 8, 2020

Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation
Nemin Chen, MPH; Maria M. Brooks, PhD; Inmaculada Hernandez, PharmD, PhD
JAMA Network Open, February 19, 2020

Incidence and Predictors of Aspirin Discontinuation in Older Adult Veteran Nursing Home Residents at End of Life
Sydney P. Springer PharmD, MS, Maria K. Mor PhD, Florentina Sileanu MS, Xinhua Zhao PhD, Sherrie L. Aspinall PharmD, MSc, Mary Ersek PhD, RN, Joshua D. Niznik PharmD, PhD, Joseph T. Hanlon PharmD, MS, Jacob Hunnicutt PhD, Walid F. Gellad MD, MPH, Loren J. Schleiden MS, Joshua M. Thorpe PhD, MPH, Carolyn T. Thorpe PhD, MPH
Journal of the American Geriatrics Society, February 13, 2020

Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data
Essien UR, Magnani JW, Chen N, Gellad WF, Fine MJ, Hernandez I
Journal of the National Medical Association, February 5, 2020

Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010-2016
Terri V. Newman, Nemin Chen, Meiqi He, Samir Saba, Inmaculada Hernandez
American Journal of Cardiovascular Drugs, December 6, 2019

Academic Detailing in the New Era of Diabetes Medication Management
Jing Luo, Ellen Dancel, Sandeep Bains, Paul Fanikos, Michael A. Fischer
Current Diabetes Reports, November 21, 2019

Opioid Prescribing Safety Measures in Medicaid Enrollees With and Without Cancer
Patience Moyo PhD, Walid F. Gellad MD, MPH, Lindsay M. Sabik PhD, Gerald T. Cochran PhD, MSW, Evan S. Cole PhD, Adam J. Gordon MD, MPH, David K. Kelley MD, MPA, Julie M. Donohue PhD
American Journal of Preventive Medicine, October 2019

Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation
Inmaculada Hernandez, Meiqi He, Maria M. Brooks, Samir Saba, Walid F. Gellad
American Journal of Cardiovascular Drugs, September 16, 2019

Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications
Ravi J. Desai, BS; Meghan M. Good, PharmD; Alvaro San-Juan-Rodriguez, PharmD; Andrew Henriksen, BS Pharm; Francesca Cunningham, PharmD; Inmaculada Hernandez, PharmD, PhD; Chester B. Good, MD, MPH
JAMA Network Open, September 4, 2019

Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework
Amy Linsky, MD, MSc, Walid F. Gellad, MD, MPH, Jeffrey A. Linder, MD, MPH, Mark W. Friedberg, MD, MPP
Journal of the American Geriatrics Society, August 20, 2019

Statins for Primary Prevention of Cardiovascular Disease
Chester B. Good, MD, MPH; Inmaculada Hernandez, PharmD, PhD; Natasha Parekh, MD, MS
Annals of Internal Medicine, July 2, 2019

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
Inmaculada Hernandez, Meiqi He, Nemin Chen, Maria M. Brooks, Samir Saba, and Walid F. Gellad
Journal of the American Heart Association, June 18, 2019

Use of a medication-based risk adjustment index to predict mortality among veterans dually-enrolled in VA and medicare
Thomas R. Radomski, Xinhua Zhao, Joseph T. Hanlon, Joshua M. Thorpe, Carolyn T. Thorpe, Jennifer G. Naples, Florentina E. Sileanu, John P. Cashy, Jennifer A. Hale, Maria K. Mor, Leslie R.M. Hausmann, Julie M. Donohue, Katie J. Suda, Kevin T. Stroup, Chester B. Good, Michael J. Fine, Walid F. Gellad
Healthcare, April 26, 2019

Cardiac Resynchronization Therapy Using Pacemakers versus Defibrillators in Patients with Non-Ischemic Cardiomyopathy: The United States Experience from 2007 to 2014
Saba S, McLaughlin T, He M, Althouse A, Mulukutla S, Hernandez I
Heart Rhythm, April 17, 2019

Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case–Control Study
Patience Moyo, PhD; Xinhua Zhao, PhD; Carolyn T. Thorpe, PhD, MPH; Joshua M. Thorpe, PhD, MPH; Florentina E. Sileanu, MS; John P. Cashy, PhD; Jennifer A. Hale, BA; Maria K. Mor, PhD; Thomas R. Radomski, MD, MS; Julie M. Donohue, PhD; Leslie R.M. Hausmann, PhD; Joseph T. Hanlon, PharmD, MS; Chester B. Good, MD, MPH; Michael J. Fine, MD, MSc; Walid F. Gellad, MD, MPH
Annals of Internal Medicine, March 12, 2019

Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness
Yael Schenker, Seo Young Park, Kwonho Jeong, Jennifer Pruskowski, Dio Kavalieratos, Judith Resick, Amy Abernethy, Jean S. Kutner
Journal of General Internal Medicine, February 4, 2019

Deprescribing in Advanced Illness: Aligning Patient, Clinician, and Health Plan Goals
Natasha Parekh, Yael Schenker, Chester B. Good, Lynn Neilson, William H. Shrank
Journal of General Internal Medicine, February 4, 2019

Development of a required longitudinal residency experience focused on deprescribing
Jennifer Pruskowski, Pharm.D., BCPS, BCGP, CPE, Heather Sakely, Pharm.D., BCPS, BCGP, Steven Handler, M.D., Ph.D., CMD
American Journal of Health-System Pharmacy, January 21, 2019

Treating Pain—The Cannabis Conundrum
Chester B. Good, MD, MPH; Natasha Parekh, MD, MS; Kavita Fischer, MD; James Schuster, MD; Chronis Manolis, RPh; William Shrank, MD, MSHS
Annals of Internal Medicine, January 8, 2019